chrisvoncsefalvay/vaers-outcomes huggingface dataset:
My arm hurts after first dose; This spontaneous case was reported by a patient and describes the occurrence of VACCINATION SITE PAIN (My arm hurts after first dose) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (My arm hurts after first dose). At the time of the report, VACCINATION SITE PAIN (My arm hurts after first dose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       No concomitant medication were reported. No treatment information was reported.
Information has been received from a healthcare worker referring to a patient of unknown age and gender. There was no medical history or drug reaction/allergies reported. On an unknown date the patient was vaccinated with a dose of improperly stored PROQUAD (Merck) (lot # M001152, expired date 05-JUL-2017, dose and route were unknown), which was exposed under 37.2 F for 6 hours. No concomitant therapy was reported. There was no previous temperature excursion. No adverse symptoms were reported. Additional information has been requested.
tested positive to COVID-19 a few days after getting his first dose; tested positive to COVID-19 a few days after getting his first dose; This is a spontaneous report from a contactable Pharmacist. A male patient in his mid-thirties received his first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/lot number: unknown, Expiry Date: unknown) on an unknown date. A few days after getting his first dose of the vaccine, the patient was tested positive to covid 19. The reporter asked asked for the recommended interval between the infection and vaccination with the second dose. The outcome of the events was unknown.  Information about lot/ batch number has been requested.; Sender's Comments: Based on known drug safety profile, there is reasonable possibility of causal association between the events ___ and the suspect vaccine BNT162B2.
Patient received second booster dose on 4/20/2022 and had reported a few days later that she had swelling and redness around the injection site. Almost a week later, patient reported that the injection site had scabbed over and went to doctors office to be examined. Doctor reported that the site was infected and prescribed an antibiotic ointment.
not felling well for 24 hours; Sore arm; tiredness; This spontaneous case was reported by a nurse and describes the occurrence of MALAISE (not felling well for 24 hours), PAIN IN EXTREMITY (Sore arm) and FATIGUE (tiredness) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 032L20A and 026L20A) for COVID-19 vaccination.     Concurrent medical conditions included Allergy to antibiotic (Patient is allergic to Z-Pak), Allergy to arthropod sting (Patient is allergic to Bee stings), Allergic reaction (Patient is allergic to Scalps) and Osteopenia. Concomitant products included ALENDRONATE SODIUM (ALENDRONATE) for Osteopenia.   On 27-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced MALAISE (not felling well for 24 hours), PAIN IN EXTREMITY (Sore arm) and FATIGUE (tiredness). The patient was treated with PARACETAMOL (TYLENOL [PARACETAMOL]) for Adverse event, at an unspecified dose and frequency. At the time of the report, MALAISE (not felling well for 24 hours) had resolved and PAIN IN EXTREMITY (Sore arm) and FATIGUE (tiredness) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Patient reported Symptoms were not worsened they are same and patient did not experience any similar events in the past.   This case was linked to MOD-2022-527083, MOD-2022-527368 (Patient Link).
weak central pulse/low central pulse rate; Chills; Shortness of breath, Breathing difficulty; Nausea; Headache; Mild fever; Muscle pain; Articular pain; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (Shortness of breath, Breathing difficulty), PULSE ABNORMAL (weak central pulse/low central pulse rate), NAUSEA (Nausea), HEADACHE (Headache) and PYREXIA (Mild fever) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included MAGNESIUM and L-TYROSINE for an unknown indication.   On 27-May-2021 at 4:35 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Jun-2021 at 3:50 PM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 24-Jun-2021, the patient experienced DYSPNOEA (Shortness of breath, Breathing difficulty), NAUSEA (Nausea), HEADACHE (Headache), PYREXIA (Mild fever), MYALGIA (Muscle pain), ARTHRALGIA (Articular pain) and FATIGUE (Fatigue). On an unknown date, the patient experienced PULSE ABNORMAL (weak central pulse/low central pulse rate) and CHILLS (Chills). At the time of the report, DYSPNOEA (Shortness of breath, Breathing difficulty), PULSE ABNORMAL (weak central pulse/low central pulse rate), NAUSEA (Nausea), HEADACHE (Headache), PYREXIA (Mild fever), MYALGIA (Muscle pain), ARTHRALGIA (Articular pain), FATIGUE (Fatigue) and CHILLS (Chills) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 24-Jun-2021, Blood pressure measurement: decreased (Low) Decreased. On an unknown date, Heart rate: low (Low) weak, Low central pulse rate.         No treatment information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 23-Aug-2021: Significant information added - Date of first dose and concomitant medications added On 23-Aug-2021: Translation Received on 27-AUG-2021
Ten days after 2nd Pfizer vaccine developed severe pruritus and re/activation of Zoster pain.Bx revealed hypersensitivity reaction with eos. Treated with topical steroids and low dose prednisone .Resolved by 75% by March 6
Severe Arthralgia after vaccination going on 7 months and is now the most severe. All blood work comes back negative for Rheumatoid arthritis or any other conditions.  I was perfectly healthy prior to  vaccination. Now I have severe Aching joints, mostly in my knees elbows and shoulders. Severe fatigue and memory loss.  Unable to perform my job and sleep all day.
mild fever; general tiredness; This is a spontaneous report from a non-contactable consumer (reported for himself).   A male patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; solution for injection, Lot Number: Unknown), via unspecified route of administration, on 01Apr2021 as a dose 2, single for COVID-19 immunization. The patient medical history and concomitant medication were not reported. The patient previously received first dose of BNT162B2 (solution for injection, Lot number: Unknown) via unspecified route of administration, on an unspecified date as a dose 1, single for COVID-19 immunization. On 02Apr2021 the patient experienced mild fever and tiredness. Outcome of the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Patient fainted less than 5 minutes after vaccination. EMS was called to transport pt to ED for further eval, but mom and patient left the clinic.
rash all over body that got progressively worse, doctor thinks immune response to covid 19 vaccine triggered psoriasis flare, treatment with prednisone taper
Patient developed neurologic symptoms including progressive dysarthria and dysphagia consistent with myasthenia gravis.
His leg swelled. Quickly after vaccine he had a red ring around the injection sight that over the course of a few days grew over four inches and had a hard lump. My child wouldn?t walk for over 24 hours, limped for two days. The redness didn?t go away for over a week and now he has a hard nodule over two weeks after vaccine.
This spontaneous report as received from a registered nurse concerning unspecified number of patients. The patients medical history and current condition was unknown. On an unknown date the patients were vaccinated with 7 doses of VARIVAX (lot#, expiry not reported) that were improperly stored at a temperature outside the patient insert. Concomitant medications were not reported. No adverse effects reported and no product quality issue reported. This is one of the two reports from the same reporter. Additional information is not expected.
Jan 28th - I received the vaccine, normal side effects experienced (chills, fatigue, headache, sore injection site), symptoms resolved within 48 hours Feb 5th - noticed after itching my left arm that my injection site was swollen again, it was about the size of a silver dollar, red and hot Feb 6th - Injection site itself normal but around the site about 3in x 2in an irregular circle of swollen skin and hot to touch  (I still have this to the present day)
10/14/22 superficial venous thrombosis on right LE, with possible cellulitis.  Hypertensive urgency with type 2 NSTEMI Hospitalized, able to be discharged by 10/17 after normal stress test and started on anticoagulation.
Heavy and unusual heavy menstrual bleeding which included large clots. Period lasts for approximately 10 days, stops for 8, then starts again. Blood clots are 2-3 inches in size.
blood clots; there are day where he is slurring; he heard loud popping in his head. it was so loud thought something hit the building; His stomach is tight from top to bottom; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. Other Case identifier(s): 2022SA029849.  A 56 year-old male patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation; enoxaparin sodium (LOVENOX [ENOXAPARIN SODIUM]) (Batch/Lot number: unknown) for thrombosis. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: THROMBOSIS (medically significant), outcome "unknown", described as "blood clots"; DYSARTHRIA (non-serious), outcome "unknown", described as "there are day where he is slurring"; TINNITUS (non-serious), outcome "unknown", described as "he heard loud popping in his head. it was so loud thought something hit the building"; ABDOMINAL DISCOMFORT (non-serious), outcome "unknown", described as "His stomach is tight from top to bottom". The action taken for enoxaparin sodium was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
achiness that subsided after 22 hours after 2nd dose; fatigue that comes and goes; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (achiness that subsided after 22 hours after 2nd dose) and FATIGUE (fatigue that comes and goes) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014C21A) for COVID-19 vaccination.     No medical history provided.  Concomitant products included VITAMIN D3, VITAMIN C [ASCORBIC ACID] and BIOTIN for an unknown indication.    On 06-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-May-2021, the patient experienced PAIN (achiness that subsided after 22 hours after 2nd dose) and FATIGUE (fatigue that comes and goes). On 07-May-2021, PAIN (achiness that subsided after 22 hours after 2nd dose) had resolved. At the time of the report, FATIGUE (fatigue that comes and goes) outcome was unknown.            Treatment: Tylenol , non drowsy Claritin  Med Info Agent: Gabriella Buffolino  Warm transferred from Moderna Customer Care case number 00164404.  Patient called 13May2021 reporting side effects experienced after the 2nd dose of the Moderna vaccine.   Safety follow up consent granted. Phone was only method of contact patient would provide says "they can call me"   Agent stated no guarantee or timeline of safety follow up, stated it is in the event the safety team needs to follow up with this case.   Healthcare provider follow up consent declined.  Patient reports having fatigue that comes and goes since receiving the 2nd dose of Moderna vaccine and that she experienced achiness that subsided 22 hours after getting the 2nd dose.   1st dose: 8Apr2021 Lot# #032B21A Expiration: not on vaccine card. Patient did not report side effects after the 1st dose.  2nd dose: 6May2021 Lot #014C21A  Expiration: not on vaccine card. States handwriting on vaccine card is "hard to read".   Concomitant medications: "mild blood pressure pill"    This case was linked to MOD-2021-073933 (Patient Link).
covid 19; This spontaneous case was reported by a patient family member or friend and describes the occurrence of COVID-19 (covid 19) in a 36-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced COVID-19 (covid 19). The patient was treated with NIRMATRELVIR, RITONAVIR (PAXLOVID) at an unspecified dose and frequency. At the time of the report, COVID-19 (covid 19) had resolved.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication details not reported by the reporter.   This case was linked to US-MODERNATX, INC.-MOD-2023-737197, US-MODERNATX, INC.-MOD-2023-737201 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-737201:Second Son Case US-MODERNATX, INC.-MOD-2023-737197:First son case
A week after having the shot, started having a rash and itching where I got the shot.
Shortness of breath. O2 reading 76 when walking across room. Reading returns to normal upon sitiing, laying down. Fluttering heart also.
Rash developed on arms, under arms, shins, head. Rash around ZOSTAVAX injection site appeared first about 2 days after injection. Rash spread to other arms/shins about a week later. Rash itches but does not burn or tingle.
Pt recvd 3 doses of Engerix-B 7MAY91, 4JUN91, & 11NOV91 & 11NOV91 immed p/3rd inject, pt exp burning while inject was being given which cont for a few hrs;
When vaccine was administered, a stream of blood came out of patient's arm.  Was able to stop bleeding by applying pressure for a couple minutes.  Right when bleeding stopped, patient shuddered slightly and started to faint. Patient was responsive again in less than a minute. She sat for approximately 5 minutes and was able to get up and walk to waiting room.  Patient was observed for an additional 20-30 minutes and she said she felt fine. Patient left pharmacy with father.
Bell's palsy. Treatment included course of steroids and anti-virals. On 11/4/21, I started having ear pain and eye twitching. On 11/5/21, I suffered from L-sided facial paralysis, pain, inability to close L eye,  decreased taste sensitivity, pins/needles, and decreased sensation.
Patient with onset of UTI symptoms (unclear when), Urine positive, cx positive for E. coli, treated with antibiotics.
Approximately 4pm 8/3, child received 3 vaccines MMR, DTaP, IPV. Mom called 9AM 8/4 left arm swollen, red. Came in for appointment 4pm 8/4 with cellulitis/ immunization rxn left arm.
Information has been received from a physician concerning a female patient who on 26-JAN-2007 was vaccinated with a first dose of Gardasil (yeast). On 26-JAN-2007 the patient experienced itching and a rash around the area of the arm and the back of the knee. The rash continued to worsen and medication was ordered to treat the rash. At the time of this report, the patient's outcome was unknown. It was noted that the patient will not receive the second and third dose of the vaccine. No product quality complaint was involved. Additional information has been requested. This is in follow-up to report (s) previously submitted on 2/14/2007. Information has been receivced from a physician concerning a female patient who on 26-JAN-2007 was vaccinated with a first dose of GARDASIL. On 26-JAN-2007 the patient experienced itching and a rash around the area of the arm and the back of the knee. The nurse stated that the rash began in the crevices of the elbows and knees and progressed to other parts of the body before the medicine was ordered to stop the itching. The rash continued to worsen and medication was ordered to treat the rash. At the time of this report, the patient's outcome was unknown. It was noted that the patient will not receive the second and third dose of the vaccine. No product quality complaint was involved. Additional information has been requested.
Patient reported feeling foggy, and appeared pale. Patient also reported dry mouth, given water and that did subside. Fogginess continued but mentation appeared delayed. EMTs brought to evaluate patient. Vital signs taken, full neuro assessment was completed. Gait was weak and unbalance when moving toward stretcher. Patient was sent to Emergency Room via EMT with medic assistance.
pt recvd vax & devel flu-like synd, cough & fatigue about 5 hrs post inject & is still presisting; inc pulse rate, tachycardia, body aches, fever & malaise;
While in observation area patient reported being light headed .  Several minutes later she reported tingling on tongue . I gave her a diphenhydramine 50mg injection and observed for about 7 minutes when she reported tightness in her chest . I injected epinephrine .3mg intramuscularly in the right thigh.  I proceeded to call 911 for transportation to medical facility.
Patient received vaccination at about 3:30P.  After 15 minute monitoring period, patient left the facility and returned at 4PM with concern of throat swelling and rash.  Benadryl 25 mg given to patient at 4:05PM.  Patient additionally complains of numbness from Arm to Neck and ringing of the ear. At 4:15 patient reassessed, throat was feeling better.  At 4:30P, patient felt improved and was ready to leave facility.
I received the Moderna COVID booster (3rd dose) at 6pm on 10/28/2021. Immediately after the shot was given, the injection site bled. It took 4 cotton balls and 2 band-aids to stop the bleeding. The skin at the injection site immediately swelled. Within 5 minutes of the injection, I started feeling nauseous and broke out in a cold sweat. I recognized this as a vasovagal response, as similar symptoms happen to me occasionally after blood donation.  I laid down on the floor and the pharmacist brought me an ice pack for the back of my neck. Symptoms subsided within 15 minutes, and after 30 minutes I felt normal and was able to drive home without further incident. By the morning of 10/29/2021, the injection site is swollen and painful with a visible bruise, well within the scope of normal adverse reactions. No other symptoms are noted at this time.
Around 4 hours after receiving shot I started feeling pain and numbness in the fifth toe on my right foot. Today (4/9) I started feeling the same pain and numbness in my second toe on my right foot. The toes with pain and numbness are more red than my other toes.
devel rash (blisters) couple of days p/vax c/o itching; denies pustular progression which might indicate chicken pox; advised to see MD; 8FEB95 saw MD couldn't determine cause but not related to vax;
Sudden onset of sharp, acute pain to right shoulder(arm vaccine received). Unable to move arm against gravity for 12-24 hours post vaccine. Continued pain to right shoulder, 1 month post vaccine (sharp, acute muscular-type pain). ***Vaccine administered very high in shoulder, higher than any other shot received prior***  Treatment: Rest as able  Outcome: Some decreased pain, however still present with certain RUE (right arm) movements
- Vaginal bleeding started about 0600 on 09/02/2021; not menstrual bleeding. Consistency and color not typical of my monthly  menstrual bleeding. Currently monitoring.  - Also experiencing mild joint pain (elbow, wrist)  in injection arm - started evening of vaccination date (9/1/21) and not yet resolved; experienced mild numbness and tingling in hand on injection arm early morning of 09/02/2021.
This does not have to do with the vaccine.  Someone who contacted me about my answers regarding the vaccine told me to let you know through here.  After having COVID, I started "falling".  It became progressively worse and in the fall of 2021, I went to see my Neurologist.  MRI and EEG came back negative and he said he thought I was having seizures because of the way it takes me a while to come back.  I become forgetful and can't remember anything.  He just told me to rest when I started feeling this way.  I have been unable to work because of my forgetfulness (I can't even follow a recipe).  I can't drive when I feel it coming on.  I will wake up in the morning feeling "off" and can't do anything other than rest until it passes.
Patient awoke following day with severe pain in right arm. Had fever of 102 by evening. ached all over body. Went to ER. Diagnosed with cellulitis @ site. Given augmentin and sent home.
Diagnosis corresponded most closely to the diagnostic and statistical manual of mental disorders-3rd edition category of major depressive disorder. A major depressive disorder, mood depressingly interferes with daily functioning, and agitation or retardation; slowed thinking. "I am unable to work as a result of my medical conditions. The mental status of speech, thought patterns, and memory has been affected. My damaged way of thinking, judgment because of mania, has caused serious problems consisting of social behavior, behavioral of withdrawal, especially amnesia. Of these behaviors and the lasting consequences. Respiratory system: frequent: cough increased, sinisitis, infrequent: epistaxis, bronchitis, asthma, pneumonia; rare: asphyxia, laryngitis, pneumothorax, hiccup. Skin and appendages: frequent: pruritus, rash; infrequent: acene, exfoliative dermatisis, dry skin, herpes simples, alopecia; rare: urticaria, herpes zoster, skin hypertrophy, seborrhea, skin ulcer. Special senses: infrequent: eye pain, abnormality of accomodation, conjunctivitis, deafness, keratoconjunctivitis, lacrimation disorder, glaucoma, hyperausis, ear pain; rare: blepharitis, partial transitory deafness, otitis media, taste loss, parosmia. Urogenital system: frequent: urinary tract infection; infrequent: kidney calculus, cystitis, dysuria, urinary incontinence, urinary retention, vaginitis, hematuria, breast pain, amenorrhea, dysmenorrhea, leukorrhea, impotence; rare: polyuria, urethritis, metrorrhagia, menorrhagia, abnormal ejaculation, breast engorgement, urinary urgency.